Being Transparent About Brilliant Failures: An Attempt to Use Real-World Data in a Disease Model for Patients with Castration-Resistant Prostate Cancer
-
Published:2022-03-21
Issue:2
Volume:9
Page:275-285
-
ISSN:2199-1154
-
Container-title:Drugs - Real World Outcomes
-
language:en
-
Short-container-title:Drugs - Real World Outcomes
Author:
Holleman Marscha S.ORCID, Huygens Simone A., Al Maiwenn J., Kuppen Malou C. P., Westgeest Hans M., van den Bergh Alfonsus C. M., Bergman Andries M., van den Eertwegh Alfonsus J. M., Hendriks Mathijs P., Lampe Menuhin I., Mehra Niven, van Moorselaar Reindert J. A., van Oort Inge M., Somford Diederik M., de Wit Ronald, van de Wouw Agnes J., Gerritsen Winald R., Groot Carin A. Uyl-de
Funder
Janssen-Cilag B.V. Astellas Pharma B.V. Bayer B.V. Sanofi-Aventis Netherlands B.V.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical)
Reference30 articles.
1. Nederlandse Kankerregistratie. In: No title. 2019. https://www.cijfersoverkanker.nl/. Accessed Feb 2019. 2. Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Cumberbatch MG, De Santis M, Fanti S, Fossati N, Gandaglia G, Gillessen S, Grivas N, Grummet J, Henry AM, der Kwast THV, Lam TB, Lardas M, Liew M, Mason MD, Moris L, Oprea-Lager DE, der Poel HGV, Rouvière O, Schoots IG, Tilki D, Wiegel T, Willemse PM, Mottet N. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021;79:263–82. 3. Nederlandse Vereniging voor Urologie. In: Prostaatcarcinoom. 2019. https://www.oncoline.nl/index.php?pagina=/richtlijn/item/pagina.php&richtlijn_id=980. 2020. 4. Parker CC, James ND, Brawley CD, Clarke NW, Hoyle AP, Ali A, Ritchie AWS, Attard G, Chowdhury S, Cross W, Dearnaley DP, Gillessen S, Gilson C, Jones RJ, Langley RE, Malik ZI, Mason MD, Matheson D, Millman R, Russell JM, Thalmann GN, Amos CL, Alonzi R, Bahl A, Birtle A, Din O, Douis H, Eswar C, Gale J, Gannon MR, Jonnada S, Khaksar S, Lester JF, O’Sullivan J, Parikh OA, Pedley ID, Pudney DM, Sheehan DJ, Srihari NN, Tran ATH, Parmar MKB, Sydes MR. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial Invalid date. Lancet. 2018;392:2353–66. 5. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, Mason M, Matveev V, Wiegel T, Zattoni F, Mottet N. EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate CancerInvalid date. Eur Urol. 2013. https://doi.org/10.1016/j.eururo.2013.11.002.
|
|